Sex-Specific Association of the X Chromosome With Cognitive Change and Tau Pathology in Aging and Alzheimer Disease.
Sex-Specific Association of the X Chromosome With Cognitive Change and Tau Pathology in Aging and Alzheimer Disease.
复制标题
DOI:
10.1001/jamaneurol.2021.2806
复制
发表时间:
2021-10-01
期刊:
影响因子:
29
通讯作者:
Dubal DB
中科院分区:
文献类型:
--
作者:
Davis EJ;Solsberg CW;White CC;Miñones-Moyano E;Sirota M;Chibnik L;Bennett DA;De Jager PL;Yokoyama JS;Dubal DB
This cohort study determines whether the X chromosome is associated with sex-specific cognitive change and tau pathology in aging and Alzheimer disease. Is X chromosome gene expression in the brain associated with cognitive change or tau pathology in aging and Alzheimer disease in women and men? In this cohort study of 508 individuals, X chromosome gene expression assessed by RNA sequencing was associated with cognitive change in women but not men in a manner independent of Alzheimer disease pathology. In contrast with cognition, X chromosome gene expression was associated with neuropathologic tau burden in men but not women. The X chromosome transcriptome, representing a significant portion of the genome of women and men, is associated with cognitive trajectories and neuropathological tau burden in aging and Alzheimer disease in a sex-specific manner. The X chromosome represents 5% of the human genome in women and men, and its influence on cognitive aging and Alzheimer disease (AD) is largely unknown. To determine whether the X chromosome is associated with sex-specific cognitive change and tau pathology in aging and AD. This study examined differential gene expression profiling of the X chromosome from an RNA sequencing data set of the dorsolateral prefrontal cortex obtained from autopsied, elderly individuals enrolled in the Religious Orders Study and Rush Memory and Aging Project joint cohorts. Samples were collected from the cohort study with enrollment from 1994 to 2017. Data were last analyzed in May 2021. The main analysis examined whether X chromosome gene expression measured by RNA sequencing of the dorsolateral prefrontal cortex was associated with cognitive change during aging and AD, independent of AD pathology and at the transcriptome-wide level in women and men. Whether X chromosome gene expression was associated with neurofibrillary tangle burden, a measure of tau pathology that influences cognition, in women and men was also explored. Samples for RNA sequencing of the dorsolateral prefrontal cortex were obtained from 508 individuals (mean [SD] age at death, 88.4 [6.6] years; 315 [62.0%] were female; 197 [38.8%] had clinical diagnosis of AD at death; 293 [58.2%] had pathological diagnosis of AD at death) enrolled in the Religious Orders Study and Rush Memory and Aging Project joint cohorts and were followed up annually for a mean (SD) of 6.3 (3.9) years. X chromosome gene expression (29 genes), adjusted for age at death, education, and AD pathology, was significantly associated with cognitive change at the genome-wide level in women but not men. In the majority of identified X genes (19 genes), increased expression was associated with slower cognitive decline in women. In contrast with cognition, X chromosome gene expression (3 genes), adjusted for age at death and education, was associated with neuropathological tau burden at the genome-wide level in men but not women. In this study, the X chromosome was associated with cognitive trajectories and neuropathological tau burden in aging and AD in a sex-specific manner. This is important because specific X chromosome factors could contribute risk or resilience to biological pathways of aging and AD in women, men, or both.
登录
查看更多内容
影响因子:
16.6
作者:
Natarajan P;Pampana A;Graham SE;Ruotsalainen SE;Perry JA;de Vries PS;Broome JG;Pirruccello JP;Honigberg MC;Aragam K;Wolford B;Brody JA;Antonacci-Fulton L;Arden M;Aslibekyan S;Assimes TL;Ballantyne CM;Bielak LF;Bis JC;Cade BE;Do R;Doddapaneni H;Emery LS;Hung YJ;Irvin MR;Khan AT;Lange L;Lee J;Lemaitre RN;Martin LW;Metcalf G;Montasser ME;Moon JY;Muzny D;O'Connell JR;Palmer ND;Peralta JM;Peyser PA;Stilp AM;Tsai M;Wang FF;Weeks DE;Yanek LR;Wilson JG;Abecasis G;Arnett DK;Becker LC;Blangero J;Boerwinkle E;Bowden DW;Chang YC;Chen YI;Choi WJ;Correa A;Curran JE;Daly MJ;Dutcher SK;Ellinor PT;Fornage M;Freedman BI;Gabriel S;Germer S;Gibbs RA;He J;Hveem K;Jarvik GP;Kaplan RC;Kardia SLR;Kenny E;Kim RW;Kooperberg C;Laurie CC;Lee S;Lloyd-Jones DM;Loos RJF;Lubitz SA;Mathias RA;Martinez KAV;McGarvey ST;Mitchell BD;Nickerson DA;North KE;Palotie A;Park CJ;Psaty BM;Rao DC;Redline S;Reiner AP;Seo D;Seo JS;Smith AV;Tracy RP;Vasan RS;Kathiresan S;Cupples LA;Rotter JI;Morrison AC;Rich SS;Ripatti S;Willer C;NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium;FinnGen;Peloso GM
通讯作者:
Peloso GM
影响因子:
25
作者:
Mostafavi S;Gaiteri C;Sullivan SE;White CC;Tasaki S;Xu J;Taga M;Klein HU;Patrick E;Komashko V;McCabe C;Smith R;Bradshaw EM;Root DE;Regev A;Yu L;Chibnik LB;Schneider JA;Young-Pearse TL;Bennett DA;De Jager PL
通讯作者:
De Jager PL
DOI:
10.3233/jad-179939
发表时间:
2018
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
Bennett DA;Buchman AS;Boyle PA;Barnes LL;Wilson RS;Schneider JA
通讯作者:
Schneider JA
影响因子:
9.8
作者:
Wise, Anastasia L.;Gyi, Lin;Manolio, Teri A.
通讯作者:
Manolio, Teri A.
影响因子:
25
作者:
Grubman, Alexandra;Chew, Gabriel;Polo, Jose M.
通讯作者:
Polo, Jose M.